home / stock / alrn / alrn news


ALRN News and Press, Aileron Therapeutics Inc. From 01/06/21

Stock Information

Company Name: Aileron Therapeutics Inc.
Stock Symbol: ALRN
Market: NASDAQ
Website: aileronrx.com

Menu

ALRN ALRN Quote ALRN Short ALRN News ALRN Articles ALRN Message Board
Get ALRN Alerts

News, Short Squeeze, Breakout and More Instantly...

ALRN - Aileron Therapeutics Announces $35.9 Million Registered Direct Offering

WATERTOWN, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN), today announced that it has entered into definitive agreements with fundamental healthcare investors for the purchase and sale of 32,630,983 of its shares of common stock at a purchase price of $1...

ALRN - CHU, CHL, FUBO and SKLZ among premarket gainers

Aileron Therapeutics (ALRN) +73%.Broadway Financial Corporation (BYFC) +55% after regulatory approvals for merger with CFBanc Corporation.Atlantic American Corporation (AAME) +43%.Marker Therapeutics (MRKR) +30% after FDA lifted the partial clinical hold on it's Phase 2 trial.Cyclo ...

ALRN - Nano Dimension (NNDM), Triterras (TRIT), MicroVision (MVIS) and Bridgetown Holdings (BTWN) among premarket gainers

SIFCO Industries (SIF) +54% on Q4 results.Creative Realities (CREX) +21%.Triterras (TRIT) +19%.AIM ImmunoTech (AIM) +17%.Bridgetown Holdings Limited (BTWN) +16%.Lightbridge Corporation (LTBR) +24% after nabbing patent in Eurasia for nuclear fuel assemblies.IZEA Worldwide (IZEA) +15%...

ALRN - Aileron Therapeutics Provides Business Update and Outlines 2021 Strategic Priorities

Aileron’s 2021 strategic priorities aim to advance its vision to bring chemoprotection to all patients with p53-mutant cancers regardless of cancer indication or chemotherapy. Key anticipated milestones include: -- Initiate Phase 1b randomized, placebo-controlled clinical t...

ALRN - Aileron Therapeutics EPS in-line

Aileron Therapeutics (ALRN): Q3 GAAP EPS of -$0.13 in-line.Cash, cash equivalents and investments of $14.1M.Press Release For further details see: Aileron Therapeutics EPS in-line

ALRN - Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights

Presented positive clinical proof-of-concept data from ongoing ALRN-6924 Phase 1b trial in patients with p53-mutated small cell lung cancer (SCLC) treated with topotecan in late-breaking presentation at 2020 EORTC-NCI-AACR Annual Symposium Phase 1b randomized, controlled trial in pa...

ALRN - Mastercard, Akamai Technologies leads premarket losers' pack

Neovasc NVCN -38% as FDA Ad Com thumbs down on Neovasc Reducer.Akerna (KERN) -16%.Six Flags Entertainment SIX -11% on Q3 earnings release.Bed Bath & Beyond BBBY -10% on announcing buyback activity after selling assets.Big 5 Sporting Goods BGFV -9% o...

ALRN - AIG, HSBC, XLNX and EXAS among premarket gainers

1847 Goedeker (GOED) +81% on announcing agreement for the acquisition of Appliances Connection.SPI Energy (SPI) +40%.Sunworks (SUNW) +17%.Xilinx (XLNX) +13% as AMD to acquire the company in an all-stock transaction valued at $35B.Neptune Wellness Solutions (NEPT) +13% ...

ALRN - SAP, DNKN, CODX and NNDM among midday movers

Gainers: Document Security Systems (DSS) +43%.Muscle Maker (GRIL) +39%.Lianluo Smart (LLIT) +35%.Co-Diagnostics (CODX) +19%.SilverSun Technologies (SSNT) +18%.Mid-Con Energy Partners (MCEP) +18%.Galera Therapeutics (GRTX) +15%.Dunkin' Brands (DNKN) +15%.GeoVax Labs (GOVX) +14%.Selec...

ALRN - Lianluo Smart, Galera Therapeutics leads healthcare gainers; BioSig Technologies, Aileron Therapeutics among major losers

Gainers: Lianluo Smart (LLIT) +30%, Galera Therapeutics (GRTX) +18%, Selecta Biosciences (SELB) +16%, Mirati Therapeutics (MRTX) +14%, GeoVax Labs (GOVX) +14%.Losers: BioSig Technologies (BSGM) -40%, Aileron Therapeutics (ALRN) ...

Previous 10 Next 10